New RECELL System Data to be Presented at 43rd Annual John A. Boswick Burn & Wound Care Symposium

Presentations include data highlighting real-world use of RECELL in combination with complementary treatments, clinical versatility, and cost effectiveness of RECELL to advance patient care

VALENCIA, Calif. and MELBOURNE, Australia., April 15, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today announced that nine abstracts highlighting the clinical and cost-savings benefits of the RECELL Autologous Cell Harvesting Device (RECELL System) have been accepted at the 43^rd Annual John A. Boswick Burn & Wound Care Symposium. The international conference will be held in Maui, Hawaii, April 17-22, 2021, and covers the latest advancements in burn care, wound healing, and infection control.

“The strong presence and broad range of physician-initiated data at this year’s Boswick Symposium reflects the rapidly expanding use of the RECELL System to treat burns of varying depth and size, as well as in combination with complementary surgical technologies, to advance patient care,” said Dr. Mike Perry, AVITA Medical’s Chief Executive Officer. “We remain committed to partnering with physicians and progressing our pipeline to realize the full potential of this innovative technology platform to treat a wide array of skin defects and wounds.”

RECELL System Accepted Abstracts

• A Real World Economic Evaluation of the Cost-Effectiveness of Autologous Cell Harvesting Device for the Treatment of Burns Requiring Hospitalization. Author: W Hickerson, Memphis, TN
• Autologous Skin Cell Suspension Early in the Acute Thermal Burn Injury Treatment Pathway: A Single Institution Experience. Author: N Kopari, Community Regional Medical Center, Fresno, CA
• Case Review Using Autologous Skin Cell Suspension in Combination with Widely Meshed Split-Thickness Autografts in the Treatment of Complex Soft Tissue Injuries. Author: N Kopari, Community Regional Medical Center, Fresno, CA
• Combining Two State-of-the-Art Surgical Techniques for the Treatment of Deep Second-Degree Burns. Author: S Blome-Eberwein, Lehigh Valley Hospital, Allentown, PA
• Evolving Concepts for RECELL Use. Author: R Sood, Burn and Reconstructive Centers of America, Augusta, GA
• Evolving Concepts in the Management of Coverage of Large Burns. Author: R Sood, Burn and Reconstructive Centers of America, Augusta, GA
• Implementing Autologous Skin Cell Suspension at an ABA Burn Center: A Comparison of Operative Efficiency using RECELL Versus Standard Split Thickness Autografting. Author: K Skibba, University of Rochester, NY
• Optimal Donor Sites for Autologous Cell Suspension Device (RECELL) in Pediatric Burn Reconstruction. Author: B Temple, St. Christopher's Hospital for Children, Philadelphia, PA
• RITA: A Simulation Based Training Program to Replicate Real-Life Wound Care Experiences in Burns Treated with Autologous Skin Cell Suspension. Author: C Bell, AVITA Medical, Valencia, CA